Literature DB >> 14971052

Autoantibodies in autoimmune thyroid disease promote immune complex formation with self antigens and increase B cell and CD4+ T cell proliferation in response to self antigens.

Claus Henrik Nielsen1, Laszlo Hegedüs, Robert Graham Quinton Leslie.   

Abstract

B cells are centrally involved as antigen-presenting cells in certain autoimmune diseases. To establish whether autoantibodies form immune complexes (IC) with self-antigens in autoimmune thyroid disease (AITD) and promote B cell uptake of self-antigen, sera from patients with Hashimoto's thyroiditis (HT), Graves' disease (GD) and healthy controls were incubated with human thyroglobulin (Tg) before adding normal peripheral blood mononuclear cells. The deposition of immunoglobulins and C3 fragments on B cells was then assessed. Inclusion of Tg in serum from HT patients promoted B cell capture of IgG and C3 fragments. Furthermore, the binding of Tg to B cells in preparations of normal blood cells was higher in HT serum than in serum from controls and correlated positively with the serum anti-Tg activity, as did the B and CD4+ T cell proliferation. Disruption of the three-dimensional structure of Tg by boiling reduced the proliferative responses. The data indicate that anti-Tg antibodies associated with AITD facilitate the formation of complement-activating Tg/anti-Tg complexes, binding of IC to B cells, and the subsequent proliferation of B and T cell subsets. This represents a novel mechanism for the maintenance of autoimmune processes in AITD and links autoreactive T cell responses with the presence of autoantibodies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14971052     DOI: 10.1002/eji.200324413

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  16 in total

Review 1.  Targeted biological therapies for Graves' disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab.

Authors:  Laszlo Hegedüs; Terry J Smith; Raymond S Douglas; Claus H Nielsen
Journal:  Clin Endocrinol (Oxf)       Date:  2011-01       Impact factor: 3.478

2.  Avidity of thyroglobulin antibody in sera from patients with Hashimoto's thyroiditis with different thyroid functional status.

Authors:  Y Zhang; Y Gao; M Li; L Xie; Y Huang; Y Gao; X Guo
Journal:  Clin Exp Immunol       Date:  2010-05-10       Impact factor: 4.330

3.  Production of interleukin (IL)-5 and IL-10 accompanies T helper cell type 1 (Th1) cytokine responses to a major thyroid self-antigen, thyroglobulin, in health and autoimmune thyroid disease.

Authors:  C H Nielsen; L Hegedüs; K Rieneck; A C Moeller; R G Q Leslie; K Bendtzen
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

Review 4.  Cancer immunotherapy - immune checkpoint blockade and associated endocrinopathies.

Authors:  David J Byun; Jedd D Wolchok; Lynne M Rosenberg; Monica Girotra
Journal:  Nat Rev Endocrinol       Date:  2017-01-20       Impact factor: 43.330

5.  Systemic adverse events following rituximab therapy in patients with Graves' disease.

Authors:  D El Fassi; C H Nielsen; P Junker; H C Hasselbalch; L Hegedüs
Journal:  J Endocrinol Invest       Date:  2010-12-15       Impact factor: 4.256

6.  Methotrexate induces poly(ADP-ribose) polymerase-dependent, caspase 3-independent apoptosis in subsets of proliferating CD4+ T cells.

Authors:  C H Nielsen; L Albertsen; K Bendtzen; B Baslund
Journal:  Clin Exp Immunol       Date:  2007-02-07       Impact factor: 4.330

Review 7.  Thyroid dysfunction: an autoimmune aspect.

Authors:  Farah Aziz Khan; Noura Al-Jameil; Mohammad Fareed Khan; May Al-Rashid; Hajera Tabassum
Journal:  Int J Clin Exp Med       Date:  2015-05-15

8.  The self-antigen, thyroglobulin, induces antigen-experienced CD4+ T cells from healthy donors to proliferate and promote production of the regulatory cytokine, interleukin-10, by monocytes.

Authors:  Claus H Nielsen; Marcel P Galdiers; Chris J Hedegaard; R Graham Q Leslie
Journal:  Immunology       Date:  2009-10-21       Impact factor: 7.397

Review 9.  Thyroglobulin as an autoantigen: what can we learn about immunopathogenicity from the correlation of antigenic properties with protein structure?

Authors:  Fabrizio Gentile; Marisa Conte; Silvestro Formisano
Journal:  Immunology       Date:  2004-05       Impact factor: 7.397

10.  Autoantibodies against complement C1q correlate with the thyroid function in patients with autoimmune thyroid disease.

Authors:  E Potlukova; J Jiskra; Z Limanova; P Kralikova; D Smutek; H Mareckova; M Antosova; M Trendelenburg
Journal:  Clin Exp Immunol       Date:  2008-05-23       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.